Skip to main content
Premium Trial:

Request an Annual Quote

GSK Licenses Compendia's Oncomine for Cancer Drug Studies

NEW YORK (GenomeWeb News) – GlaxoSmithKline has licensed Compendia Bioscience’s Oncomine Enterprise Edition database for use in its cancer research programs, Compendia said today.
 
The pharmaceutical company has licensed the database, which is an extension of the Oncomine line, under a two-year agreement.
 
The Oncomine database is a compendium of nearly 26,000 gene expression and DNA copy number profiles taken from scientific literature and other public sources, and it uses gene sets to enable “researchers to discover and explore new biology based on signatures related to drugs and/or disease pathways,” Compendia said.
 
Financial terms of the agreement were not released.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.